ILUMIEN-V - AERO STUDY
With the approval of the principal ethics committee in Germany, another important milestone has been achieved for the Institute for Myocardial Infarction Research.
Read more
Your publications are your success
We have only done our job well if you are successful.
Trust in data
Your data is ready. It has been checked, cleaned up and is now in a standardised format. We evaluate your data together with you. You ask the questions and we provide the analysis.
You can rely on the quality of your data and your results.
Publish and present
We work together with you on your presentations and publications. You can rely on us in review processes too. We are experts in the field and we specialise in cardiovascular diseases. We are able to work closely with you to provide fast responses, check everything one last time and answer any remaining questions.
We’ll also work late into the night to do this when necessary.
Your idea - your success
We congratulate you and celebrate with you. And we are already looking forward to your next idea.
Services
Integrated randomisation
Data Management Plans
GCP requirements
Interim/final reports
CRF design
Status reports
Survival analyses
Fully automatic edit checks
Law on the Reorganisation of the Pharmaceutical Market (AMNOG) reports
Data Validation Plans
Hypothesis testing
Publication manuscripts
Data Export Plans
21 CFR Part 11
Descriptive analyses
Line listings
Lecture manuscripts
DSMB support
Query management
Data review
Multivariate models
News
Long-Term Care of Myocardial Infarction Patients in Germany - First Results from the GULLIVE-R Project
First results introduced during the 88th annual meeting of the DGK in Mannheim byProf. Uwe Zeymer, Chairman of the Foundation Institute for Myocardial Infarction Research and Principal Investigator of the GULLIVE-R study.
Read more
CRUZ-SENIOR STUDY FRANCE: FIRST PATIENT IN
Dr. Matthieu Godin and his study team from Clinique Saint Hilaire in Rouen, and Dr. Christophe Robin and his study team from Clinique Convert, of Bourg en Bresse are pleased to announce the successful enrollment of their first patient.
Read more